Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Reuben Gregg Brewer - How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
The Motley Fool –

Dividend investors often focus first on yield, which can lead to an overly aggressive portfolio. For example, in the pharmaceutical sector, Pfizer (PFE +1.65%) has a very attractive 6.1% yield, as of this writing. A roughly $200,000 investment in…

fool.com - Joe Tenebruso - Prediction: My Top 2 Stocks to Buy Now Will Outperform the Stock Market Over the Next Decade
Prediction: My Top 2 Stocks to Buy Now Will Outperform the Stock Market Over the Next Decade
The Motley Fool –

Winners tend to keep on winning. This is a core principle of my investing philosophy that's helped me generate market-crushing returns for investors who've followed along with my stock picks. More importantly, I believe this principle can help you…

fool.com - Robert Izquierdo - Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens
The Motley Fool –

The Invesco Pharmaceuticals ETF (PJP +1.56%) focuses on concentrated exposure to drug manufacturers with lower historical volatility, while the Invesco S&P 500 Equal Weight Health Care ETF (RSPH +1.70%) provides a more diversified, lower-cost…

swissinfo.ch - swissinfo.ch - Expert report into Crans-Montana tragedy delayed
Expert report into Crans-Montana tragedy delayed
www.swissinfo.ch –

“I can confirm that the deadline has been extended because of the complexity of the work involved,” Beatrice Pilloud, Attorney General of canton Valais, told the Keystone-SDA news agency on Sunday in response to a report by the…

thetruthaboutcancerofficial.substack.com - The Pink Ribbon Illusion: How Breast Cancer Awareness Month Became Big Pharma's Favorite Cash Cow
The Pink Ribbon Illusion: How Breast Cancer Awareness Month Became Big Pharma's Favorite Cash Cow
The Truth About Cancer –

It's October again. Break out the pink ribbons, the pink cleats, the pink yogurt lids, and the pink buckets of fried chicken. America's favorite corporate virtue-signaling ritual is upon us. For 40 years now, we've been told that…

nationalpost.com - Raymond J. de Souza: Elon Musk's unglorious moment
Raymond J. de Souza: Elon Musk's unglorious moment
National Post –

Even for the world's premiere celebrity entrepreneur, Elon Musk is having something of a moment. He was on the cover The Economist's special summer issue over the headline, “Should you be afraid of Elon Musk?” We apologize, but this…

247wallst.com - Chris Lange - 5 Dividend Stocks for Retirees Who Want More Than Just a Big Yield
5 Dividend Stocks for Retirees Who Want More Than Just a Big Yield
24/7 Wall St –

When the 10-year Treasury yields 5.22%, a dividend stock has to offer more than a big number. These five names cover telecom, net-lease real estate, consumer staples, regulated utilities and pharma. Each one supports its payout with cash flow, a…

earth.com - Eric Ralls - Scientists discover a hidden switch that helps the body burn calories
Scientists discover a hidden switch that helps the body burn calories
Earth.com –

Brown fat runs on a timetable. In mice and in people, its fuel burning climbs just before waking and falls to its lowest point during sleep. Yet cold exposure and dietary changes can also influence its activity, independently of the daily schedule.

marketbeat.com - Astrazeneca (NYSE:AZN) Downgraded by Wall Street Zen to 'Hold'
Astrazeneca (NYSE:AZN) Downgraded by Wall Street Zen to 'Hold'
MarketBeat –

Astrazeneca (NYSE:AZN - Get Free Report) was downgraded by Wall Street Zen from a 'buy' rating to a 'hold' rating in a research note issued to investors on Sunday, Wall Street Zen reports. The Phase 3 Failure That Sent Biotech Winners and Losers in…

marketbeat.com - Eli Lilly and Company $LLY Stock: Oak Grove Capital LLC Raises Stake
Eli Lilly and Company $LLY Stock: Oak Grove Capital LLC Raises Stake
MarketBeat –

Oak Grove Capital LLC raised its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 61.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,238 shares of the company's stock…

Receive a Daily briefing on Pharma Industry News

Get Started